FTO‐mediated m6A Methylation of KCNAB2 Inhibits Tumor Property of Non‐Small Cell Lung Cancer Cells and M2 Macrophage Polarization by Inactivating the PI3K/AKT Pathway
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Yanguang Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of thoracic surgery, Cangzhou Central Hospital, Cangzhou City, Hebei Province, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Proto-Oncogene Proteins c-akt, Alpha-Ketoglutarate-Dependent Dioxygenase FTO. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Potassium voltage‐gated channel subfamily A regulatory beta subunit 2 (KCNAB2) is a potassium voltage‐gated channel subfamily A member that plays a role in non‐small cell lung cancer (NSCLC). However, its functional impact and mechanism in NSCLC are not fully understood. Here, we analyzed its effects on NSCLC cell behaviors and the underlying mechanism.mRNA expression levels were detected by quantitative real‐time polymerase chain reaction (qRT‐PCR),(qRT‐PCR), while protein expression was quantified by western blotting blot analysis or immunohistochemistry assay. NSCLC cell proliferation, migration, invasion, macrophage polarization, and apoptosis were evaluated through cell‐based assays including cell counting kit‐8 (CCK‐8)(CCK‐8) assay, flow cytometry, Tunel assay, wound‐healing assay, and transwell invasion assay. The role of FTO alpha‐ketoglutarate dependent dioxygenase (FTO)‐mediated(FTO)‐mediated m6A methylation in the regulation of KCNAB2 expression and their impacts on NSCLC cell behavior and M2 macrophage polarization were assessed through m6A RNA immunoprecipitation assay and rescue experiments. Xenograft mouse model assay was used to determine the effect of KCNAB2 on tumor formation in vivo .in vivo.KCNAB2 expression was downregulated and FTO expression was upregulated in NSCLC tissues and cells when compared with controls. Moreover, the expression of KCNAB2 was found to be lower in stage III NSCLC patients compared to those at stages I and II, and it was also lower in patients with positive lymph node metastasis compared to those with negative lymph node metastasis. Overexpression of KCNAB2 inhibited NSCLC cell proliferation, migration, invasion, and M2 macrophage polarization, while inducing cell apoptosis. These effects were mediated, at least partially, by inactivating the phosphoinositide 3‐kinase (PI3K)/AKT(PI3K)/AKT pathway. Moreover, ectopic expression of KCNAB2 delayed tumor formation in vivo . FTOin vivo. FTO was found to mediate m6A methylation of KCNAB2, and knockdown of FTO resulted in the upregulation of KCNAB2 expression, leading to inhibition of NSCLC cell behavior and M2 macrophage polarization.KCNAB2 overexpression inhibited NSCLC cell behavior and M2 macrophage polarization by inactivating the PI3KPI3K/AKT/AKT pathway. Furthermore, FTOFTO‐mediated‐mediated m6A methylation was involved in the regulation of KCNAB2 expression in NSCLC. These results enhance our understanding of the role of KCNAB2 in NSCLC and suggest its potential as a therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of thoracic surgery, Cangzhou Central Hospital, Cangzhou City, Hebei Province, China.
- Department of geriatric internal medicine, Cangzhou Central Hospital, Cangzhou City, Hebei Province, China.
- Department of thoracic surgery, Cangzhou Hospital of Integrated TCM-WM, Cangzhou City, Hebei Province, China.
- Department 3 of thoracic, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, China.
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Li, Y., Niu, J., Sun, Z., & Liu, J. (2025). FTO‐mediated m6A Methylation of KCNAB2 Inhibits Tumor Property of Non‐Small Cell Lung Cancer Cells and M2 Macrophage Polarization by Inactivating the PI3K/AKT Pathway. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70232
Vancouver
Li Y, Niu J, Sun Z, Liu J. FTO‐mediated m6A Methylation of KCNAB2 Inhibits Tumor Property of Non‐Small Cell Lung Cancer Cells and M2 Macrophage Polarization by Inactivating the PI3K/AKT Pathway. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70232
BibTeX
@article{Li2025,
author = {Li, Yanguang and Niu, Jieting and Sun, Zhiguang and Liu, Junfeng},
title = {FTO‐mediated m6A Methylation of KCNAB2 Inhibits Tumor Property of Non‐Small Cell Lung Cancer Cells and M2 Macrophage Polarization by Inactivating the PI3K/AKT Pathway},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70232}
}
EUVIMED